The efficacy and tolerance of treatment with combination of cholinesterase inhibitors (ChEls) in patients with Alzheimer's disease over a 12-month period

被引：0
|
作者：
Tsolaki, M. [1 ]
Bosiki, M. [1 ]
Messini, C. H. [1 ]
Kounti, F. [1 ]
Kazis, A. [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2005年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease:: a meta-analysis
    Lanctôt, KL
    Herrmann, N
    Yau, KK
    Khan, LR
    Liu, BA
    Loulou, MM
    Einarson, TR
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 169 (06) : 557 - 564
  • [42] 12-MONTH COST OF ILLNESS STUDY OF MODERATE ALZHEIMER'S DISEASE PATIENTS IN SPAIN: THE EVOCOST STUDY
    Salva, A.
    Frank-Garcia, A.
    Lereun, C.
    Gimeno, V
    Milea, D.
    Bineau, S.
    VALUE IN HEALTH, 2012, 15 (07) : A549 - A549
  • [43] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Rabins, Peter V.
    Lyketsos, Constantine G.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (11): : 578 - 579
  • [44] Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease
    Peter V Rabins
    Constantine G Lyketsos
    Nature Clinical Practice Neurology, 2006, 2 : 578 - 579
  • [45] Treatment pattern of Alzheimer's disease with cholinesterase inhibitors (train study)
    Gil-Neciga, E.
    Gobartt, A. L.
    REVISTA DE NEUROLOGIA, 2008, 46 (08) : 461 - 464
  • [46] Researchers find differences in treatment of Alzheimer's disease with cholinesterase inhibitors
    不详
    CNS SPECTRUMS, 2004, 9 (04) : 251 - 252
  • [47] Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
    Chris G. Parsons
    Wojciech Danysz
    Andrzej Dekundy
    Irena Pulte
    Neurotoxicity Research, 2013, 24 : 358 - 369
  • [48] A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease
    Ebrahem, Anees Shajhan
    Oremus, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (11) : 1245 - 1259
  • [49] An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease
    Haake, Andrea
    Nguyen, Kevin
    Friedman, Lauren
    Chakkamparambil, Binu
    Grossberg, George T.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (02) : 147 - 157
  • [50] Cholinesterase inhibitors in the treatment of Alzheimer's disease - A comparison of tolerability and pharmacology
    Nordberg, A
    Svensson, AL
    DRUG SAFETY, 1998, 19 (06) : 465 - 480
12345